# Evaluation of the Cost and Effectiveness Sunitinib Compared to Interferon-Alfa in Finland

> **NCT00980213** · — · COMPLETED · sponsor: **Pirkko-Liisa Kellokumpu-Lehtinen** · enrollment: 80 (actual)

## Conditions studied

- Neoplasms
- Renal Cell Carcinoma

## Interventions

- **DRUG:** sunitinib

## Key facts

- **NCT ID:** NCT00980213
- **Lead sponsor:** Pirkko-Liisa Kellokumpu-Lehtinen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2013-11
- **Final completion:** 2013-12
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2014-02-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00980213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00980213, "Evaluation of the Cost and Effectiveness Sunitinib Compared to Interferon-Alfa in Finland". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00980213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*